Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2) Grant US-11891638-B2 United States of America 06 Feb 2024
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Grant US-11732030-B2 United States of America 22 Aug 2023
ENRICHMENT AND CHARACTERIZATION OF RARE CIRCULATING CELLS, INCLUDING PROGENITOR CELLS… Application WO-2023150760-A2 World Intellectual Property Organisation (WIPO) 10 Aug 2023
COMBINATION OF ONE OR MORE ANTIBIOTICS OF THE ANSAMYCIN CLASS WITH ONE OR MORE OTHER… Application WO-2023095075-A1 World Intellectual Property Organisation (WIPO) 01 Jun 2023
Combinazione di uno o più antibiotici della classe delle ansamicine con uno o più altri… N/A IT-202100029909-A1 Italy 26 May 2023
VACCINE WITH IMPROVED IMMUNOGENICITY AGAINST MUTANT CORONAVIRUSES Application WO-2023089071-A1 World Intellectual Property Organisation (WIPO) 25 May 2023
VACCINE WITH IMPROVED IMMUNOGENICITY AGAINST MUTANT CORONAVIRUSES Application EP-4183409-A1 European Patent Office 24 May 2023
Determining risk of death in virally infected subjects Application KR-20230017200-A Republic of Korea 03 Feb 2023
A PHARMACEUTICAL COMPOSITION COMPRISING BAY 86-5277 AND SALTS THEREOF FOR USE IN THE… Application EP-4115885-A1 European Patent Office 11 Jan 2023
COMPOSITIONS AND METHODS FOR REDUCING CYTOKINE EXPRESSION Application WO-2022182707-A1 World Intellectual Property Organisation (WIPO) 01 Sep 2022
Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated Salmonella… Grant US-11406702-B1 United States of America 09 Aug 2022
Anti-SARS-COV-2 antibodies and uses thereof Grant US-11365239-B2 United States of America 21 Jun 2022
INHALED INTERFERON-BETA FOR IMPROVING OUTCOME IN SARS-COV-2 INFECTED PATIENTS Application WO-2022018422-A1 World Intellectual Property Organisation (WIPO) 27 Jan 2022
A CELLULAR MARKER OF COVID SEVERITY Application WO-2021250266-A1 World Intellectual Property Organisation (WIPO) 16 Dec 2021
QUANTIFICATION OF CORONAVIRUS RNAAEMIA Application WO-2021245035-A1 World Intellectual Property Organisation (WIPO) 09 Dec 2021
METHODS OF TREATING COVID-19 USING BARDOXOLONE METHYL OR ANALOGS THEREOF Application WO-2021231208-A1 World Intellectual Property Organisation (WIPO) 18 Nov 2021
PLACENTA-DERIVED ADHERENT (PDA) STEM CELL FOR THE TREATMENT OF ADULTS WITH SARS-COV-2… Application WO-2021226602-A1 World Intellectual Property Organisation (WIPO) 11 Nov 2021
NACHR, SUCH AS NICOTINE, FOR USE IN THE PREVENTION AND THE TREATMENT OF COVID-19 DISEASE Application WO-2021204814-A1 World Intellectual Property Organisation (WIPO) 14 Oct 2021
Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments Grant US-10975139-B1 United States of America 13 Apr 2021
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Grant US-10954289-B1 United States of America 23 Mar 2021